The role of p16 in suppressing spontaneous tumor formation in RB1-deficient lungs was investigated in vivo by generating double transgenic Scgb1a1-rtTA/tetCre mice wherein RB1 ablation was targeted to the lung epithelium in a p16+/− and p16−/− background (Figure 1a). Here, RB1 is linked to neoplasm.